interviews
source: by Timothy Hay When the Food and Drug Administration told personal-genetics company 23andMe Inc. in November to stop sending consumers detailed information about their DNA, some industry watchers said the move could be a devastating blow to an emerging area of medicine that holds promise for better health outcomes. But it was more of […]
Read MoreTop 5 pathways to personalized medicine Healthcare IT NewsJeff RoweJuly 22, 2013 If there’s one thing everyone in healthcare can probably agree on right now, it’s that there is an awful lot of data being generated each and every day. What to do with that data, however, is another question. As Ted Driscoll, digital health […]
Read More
November 28, 2012. Source: Nobel Profit Listen to venture capitalist Nat Goldhaber, managing director of Claremont Creek Ventures, share his insights around energy and policy in California in regards to clean tech investments. In this interview he focuses on a particular investment in solar with Clean Power Finance as it relates to the public utilities and […]
Read MoreAn energy-independent United States is an achievable goal by 2025, according to new research commissioned by Claremont Creek Ventures. In order to achieve this audacious goal, the United States needs to clear an important
set of hurdles.
July 11, 2012 source: MedCity News Ted was recently interview by MedCity News for two articles: Biggest threat to investment in mobile health startups? Not enough unique intellectual property VCs say a coachable entrepreneur, strong IP make convergence worth investing in Here are some excerpts from the interviews: Biggest threat to investment in mobile health […]
Read More
Click here to read the article, and here to visit the Clean Power Finance website.
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.